Dale Sanders, Chief Technology Officer at Health Catalyst, Inc. (HCAT), sold 35,796 shares at $35.19 ($1.3M) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market sale of $1.3M HCAT by Chief Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.19 | 1,334 | $47K | 3.7% |
| 2 | $35.19 | 8,296 | $292K | 23.0% |
| 3 | $35.19 | 8,296 | $292K | 23.0% |
| 4 | $35.70 | 17,870 | $638K | 50.3% |
| Total | $35.44 avg | 35,796 | $1.3M | 100% |
| Filing → |
| HCAT | SELL | 2020-06-03 | $742K | — | Filing → |
| HCAT | SELL | 2020-05-05 | $698K | — | Filing → |
| HCAT | SELL | 2020-04-03 | $1.4M | — | Filing → |